China begins using world's 1st inhalable COVID-19 vaccine


Shanghai, China, on Wednesday became the first location in the world to begin administering an inhalable version of the COVID-19 vaccine, The Associated Press reported.
The vaccine is given in the form of a mist sucked into the mouth. It is available to residents of Shanghai free of charge, though it is currently only being given as a booster to those who have previously been vaccinated, according to a statement from Shanghai city officials obtained by AP.
Chinese officials posted a video on social media appearing to show the process behind the oral vaccination, including what appeared to be people inhaling the contents of a translucent cup into their mouths. Chinese text overlaid by the video, translated by AP, reportedly said the entire process took around 20 seconds.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The new oral version is part of a push by Chinese officials to try and make "needle-free" vaccinations more widely available to the public. It comes as the country is still under a series of stringent COVID-19 regulations as part of Chinese President Xi Jinping's "zero-COVID" policy. While the strict lockdowns continue to be out of line with the rest of the world, China is among the globe's most inoculated nations, with 90 percent of eligible citizens fully vaccinated.
China remains the only country where this inhalable vaccine is currently available, but AP said that Malaysia would soon be undergoing clinical trials to determine its efficacy, with the potential for other nations to follow.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and other news. Justin has also freelanced for outlets including Collider and United Press International.
-
Do I qualify for student loan forgiveness?
The Explainer There are a number of different pathways to qualification, though each requires strict criteria to be met
By Becca Stanek, The Week US Published
-
These are the 8 restaurants to eat at this spring
The Week Recommends An array of cuisines at noteworthy restaurants across the US
By Scott Hocker, The Week US Published
-
'A political agenda aimed at reshaping higher education into an ideological stronghold'
instant opinion 'Opinion, comment and editorials of the day'
By Anya Jaremko-Greenwold, The Week US Published
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published